The data presented here suggest that leptin could be considered a link between immunometabolism and rheumatic diseases and regulation or modulation of its signalling pathways may represent innovative therapeutic strategies for autoimmune and rheumatic disorders. Here, LEP is linked to rheumatic disorder.